000 | 01956 a2200505 4500 | ||
---|---|---|---|
005 | 20250517030058.0 | ||
264 | 0 | _c20160217 | |
008 | 201602s 0 0 eng d | ||
022 | _a1537-6524 | ||
024 | 7 |
_a10.3109/15376516.2015.1036333 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKassa, Jiri | |
245 | 0 | 0 |
_aA comparison of the reactivating and therapeutic efficacy of two novel bispyridinium oximes (K727, K733) with the oxime HI-6 and obidoxime in sarin-poisoned rats and mice. _h[electronic resource] |
260 |
_bToxicology mechanisms and methods _cMar 2015 |
||
300 |
_a229-33 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAcetylcholinesterase _xblood |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aAnimals, Outbred Strains |
650 | 0 | 4 |
_aAntidotes _xtherapeutic use |
650 | 0 | 4 |
_aAtropine _xtherapeutic use |
650 | 0 | 4 |
_aBrain _xdrug effects |
650 | 0 | 4 |
_aCholinesterase Inhibitors _xadministration & dosage |
650 | 0 | 4 |
_aCholinesterase Reactivators _xtherapeutic use |
650 | 0 | 4 |
_aDiaphragm _xdrug effects |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aMuscarinic Antagonists _xtherapeutic use |
650 | 0 | 4 |
_aNerve Tissue Proteins _xagonists |
650 | 0 | 4 |
_aNeurons _xdrug effects |
650 | 0 | 4 |
_aNeurotoxicity Syndromes _xblood |
650 | 0 | 4 |
_aObidoxime Chloride _xtherapeutic use |
650 | 0 | 4 |
_aOximes _xtherapeutic use |
650 | 0 | 4 |
_aPyridinium Compounds _xtherapeutic use |
650 | 0 | 4 | _aRats, Wistar |
650 | 0 | 4 |
_aSarin _xadministration & dosage |
700 | 1 | _aSepsova, Vendula | |
700 | 1 | _aMatouskova, Lenka | |
700 | 1 | _aHorova, Anna | |
700 | 1 | _aMusilek, Kamil | |
773 | 0 |
_tToxicology mechanisms and methods _gvol. 25 _gno. 3 _gp. 229-33 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.3109/15376516.2015.1036333 _zAvailable from publisher's website |
999 |
_c24824771 _d24824771 |